Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank 指定難病告示番号
1 MAPK14 3件: VEGF signaling pathway, Yersinia infection, Tuberculosis D09639 Losmapimod 2件: 113, 222
2 MAPK14 3件: VEGF signaling pathway, Yersinia infection, Tuberculosis D10959 Neflamapimod 1件: 8
3 HLA-DMA 3件: Type I diabetes mellitus, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
4 HLA-DMB 3件: Type I diabetes mellitus, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
5 HLA-DOA 3件: Type I diabetes mellitus, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
6 HLA-DOB 3件: Type I diabetes mellitus, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
7 HLA-DPA1 3件: Type I diabetes mellitus, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
8 HLA-DPB1 3件: Type I diabetes mellitus, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
9 HLA-DQA1 3件: Type I diabetes mellitus, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
10 HLA-DQA2 3件: Type I diabetes mellitus, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
11 HLA-DQB1 3件: Type I diabetes mellitus, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
12 HLA-DRA 3件: Type I diabetes mellitus, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
13 HLA-DRB1 3件: Type I diabetes mellitus, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
14 HLA-DRB3 3件: Type I diabetes mellitus, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
15 HLA-DRB4 3件: Type I diabetes mellitus, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
16 HLA-DRB5 3件: Type I diabetes mellitus, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
17 IFNA1 1件: Tuberculosis D09662 Rontalizumab 1件: 49
18 IFNA1 1件: Tuberculosis D09668 Sifalimumab 1件: 49
19 IFNA2 1件: Tuberculosis D09662 Rontalizumab 1件: 49
20 IFNA2 1件: Tuberculosis D09668 Sifalimumab 1件: 49
21 IFNA4 1件: Tuberculosis D09662 Rontalizumab 1件: 49
22 IFNA4 1件: Tuberculosis D09668 Sifalimumab 1件: 49
23 IFNA5 1件: Tuberculosis D09662 Rontalizumab 1件: 49
24 IFNA5 1件: Tuberculosis D09668 Sifalimumab 1件: 49
25 IFNA6 1件: Tuberculosis D09662 Rontalizumab 1件: 49
26 IFNA6 1件: Tuberculosis D09668 Sifalimumab 1件: 49
27 IFNA7 1件: Tuberculosis D09662 Rontalizumab 1件: 49
28 IFNA7 1件: Tuberculosis D09668 Sifalimumab 1件: 49
29 IFNA8 1件: Tuberculosis D09662 Rontalizumab 1件: 49
30 IFNA8 1件: Tuberculosis D09668 Sifalimumab 1件: 49
31 IFNA10 1件: Tuberculosis D09662 Rontalizumab 1件: 49
32 IFNA10 1件: Tuberculosis D09668 Sifalimumab 1件: 49
33 IFNA13 1件: Tuberculosis D09662 Rontalizumab 1件: 49
34 IFNA13 1件: Tuberculosis D09668 Sifalimumab 1件: 49
35 IFNA14 1件: Tuberculosis D09662 Rontalizumab 1件: 49
36 IFNA14 1件: Tuberculosis D09668 Sifalimumab 1件: 49
37 IFNA16 1件: Tuberculosis D09662 Rontalizumab 1件: 49
38 IFNA16 1件: Tuberculosis D09668 Sifalimumab 1件: 49
39 IFNA17 1件: Tuberculosis D09662 Rontalizumab 1件: 49
40 IFNA17 1件: Tuberculosis D09668 Sifalimumab 1件: 49
41 IFNA21 1件: Tuberculosis D09662 Rontalizumab 1件: 49
42 IFNA21 1件: Tuberculosis D09668 Sifalimumab 1件: 49
43 IFNG 2件: Type I diabetes mellitus, Tuberculosis D04242 Fontolizumab 1件: 46
44 IFNG 2件: Type I diabetes mellitus, Tuberculosis D11120 Emapalumab 2件: 49, 107
45 IFNGR1 1件: Tuberculosis D00747 Interferon gamma-1b 7件: 18, 65, 85, 228, 299, 301, 326
46 IFNGR2 1件: Tuberculosis D00747 Interferon gamma-1b 7件: 18, 65, 85, 228, 299, 301, 326
47 IL1A 2件: Type I diabetes mellitus, Tuberculosis D01583 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
48 IL1A 2件: Type I diabetes mellitus, Tuberculosis D06635 Rilonacept 4件: 51, 106, 107, 266
49 IL1A 2件: Type I diabetes mellitus, Tuberculosis D11253 Bermekimab 1件: 51
50 IL1B 3件: Type I diabetes mellitus, Yersinia infection, Tuberculosis D01583 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
51 IL1B 3件: Type I diabetes mellitus, Yersinia infection, Tuberculosis D06635 Rilonacept 4件: 51, 106, 107, 266
52 IL1B 3件: Type I diabetes mellitus, Yersinia infection, Tuberculosis D09315 Canakinumab 10件: 46, 56, 84, 106, 107, 108, 113, 266, 267, 269
53 IL1B 3件: Type I diabetes mellitus, Yersinia infection, Tuberculosis D09911 Gevokizumab 4件: 41, 50, 56, 269
54 IL6 3件: Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, Tuberculosis D01583 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
55 IL6 3件: Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, Tuberculosis D08976 Pomalidomide 6件: 28, 34, 51, 85, 227, 331
56 IL6 3件: Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, Tuberculosis D09669 Siltuximab 2件: 28, 331
57 IL6 3件: Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, Tuberculosis D10080 Sirukumab 2件: 41, 46
58 IL10 3件: Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, Tuberculosis D01583 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
59 IL12A 2件: Type I diabetes mellitus, Tuberculosis D09214 Ustekinumab 17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271
60 IL12B 2件: Type I diabetes mellitus, Tuberculosis D09214 Ustekinumab 17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271
61 JAK1 2件: Tuberculosis, Viral carcinogenesis D09959 Ruxolitinib 1件: 228
62 JAK1 2件: Tuberculosis, Viral carcinogenesis D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
63 JAK1 2件: Tuberculosis, Viral carcinogenesis D10308 Baricitinib 13件: 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325
64 JAK1 2件: Tuberculosis, Viral carcinogenesis D10653 Peficitinib 1件: 46
65 JAK1 2件: Tuberculosis, Viral carcinogenesis D10871 Filgotinib 6件: 46, 53, 96, 97, 222, 271
66 JAK1 2件: Tuberculosis, Viral carcinogenesis D10944 Itacitinib 5件: 46, 51, 60, 97, 228
67 JAK1 2件: Tuberculosis, Viral carcinogenesis D10994 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271
68 JAK2 1件: Tuberculosis D09959 Ruxolitinib 1件: 228
69 JAK2 1件: Tuberculosis D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
70 JAK2 1件: Tuberculosis D10308 Baricitinib 13件: 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325
71 JAK2 1件: Tuberculosis D10653 Peficitinib 1件: 46
72 NFKB1 3件: Yersinia infection, Tuberculosis, Viral carcinogenesis D01146 Iguratimod 4件: 46, 51, 53, 271
73 IL23A 1件: Tuberculosis D09214 Ustekinumab 17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271
74 IL23A 1件: Tuberculosis D10400 Tildrakizumab 2件: 162, 271
75 IL23A 1件: Tuberculosis D10438 Guselkumab 5件: 37, 41, 51, 96, 97
76 IL23A 1件: Tuberculosis D10912 Brazikumab 2件: 96, 97
77 IL23A 1件: Tuberculosis D11052 Risankizumab 4件: 37, 96, 97, 271
78 IL23A 1件: Tuberculosis D11123 Mirikizumab 3件: 37, 96, 97
79 PPP3CA 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D00107 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
80 PPP3CA 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
81 PPP3CA 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D05480 Pimecrolimus 1件: 160
82 PPP3CA 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D08556 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
83 PPP3CA 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D09033 Voclosporin 1件: 222
84 PPP3CB 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D00107 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
85 PPP3CB 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
86 PPP3CB 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D05480 Pimecrolimus 1件: 160
87 PPP3CB 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D08556 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
88 PPP3CB 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D09033 Voclosporin 1件: 222
89 PPP3CC 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D00107 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
90 PPP3CC 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
91 PPP3CC 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D05480 Pimecrolimus 1件: 160
92 PPP3CC 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D08556 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
93 PPP3CC 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D09033 Voclosporin 1件: 222
94 PPP3R1 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D00107 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
95 PPP3R1 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
96 PPP3R1 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D05480 Pimecrolimus 1件: 160
97 PPP3R1 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D08556 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
98 PPP3R1 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D09033 Voclosporin 1件: 222
99 PPP3R2 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D00107 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
100 PPP3R2 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
101 PPP3R2 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D05480 Pimecrolimus 1件: 160
102 PPP3R2 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D08556 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
103 PPP3R2 3件: Wnt signaling pathway, VEGF signaling pathway, Tuberculosis D09033 Voclosporin 1件: 222
104 MAPK11 3件: VEGF signaling pathway, Yersinia infection, Tuberculosis D09639 Losmapimod 2件: 113, 222
105 MAPK11 3件: VEGF signaling pathway, Yersinia infection, Tuberculosis D10959 Neflamapimod 1件: 8
106 MAPK13 3件: VEGF signaling pathway, Yersinia infection, Tuberculosis D09639 Losmapimod 2件: 113, 222
107 MAPK13 3件: VEGF signaling pathway, Yersinia infection, Tuberculosis D10959 Neflamapimod 1件: 8
108 RAF1 3件: Vascular smooth muscle contraction, VEGF signaling pathway, Tuberculosis D06272 Sorafenib 2件: 34, 86
109 RAF1 3件: Vascular smooth muscle contraction, VEGF signaling pathway, Tuberculosis D08524 Sorafenib 2件: 34, 86
110 BCL2 1件: Tuberculosis D10679 Venetoclax 1件: 28
111 RELA 3件: Yersinia infection, Tuberculosis, Viral carcinogenesis D12181 Edasalonexent 1件: 113
112 MAPK12 3件: VEGF signaling pathway, Yersinia infection, Tuberculosis D09639 Losmapimod 2件: 113, 222
113 MAPK12 3件: VEGF signaling pathway, Yersinia infection, Tuberculosis D10959 Neflamapimod 1件: 8
114 SRC 4件: VEGF signaling pathway, Yersinia infection, Tuberculosis, Viral carcinogenesis D03252 Bosutinib 2件: 2, 67
115 SRC 4件: VEGF signaling pathway, Yersinia infection, Tuberculosis, Viral carcinogenesis D03658 Dasatinib 2件: 51, 85
116 SRC 4件: VEGF signaling pathway, Yersinia infection, Tuberculosis, Viral carcinogenesis D06414 Dasatinib 2件: 51, 85
117 SRC 4件: VEGF signaling pathway, Yersinia infection, Tuberculosis, Viral carcinogenesis D09664 Saracatinib 3件: 6, 89, 272
118 SYK 2件: Tuberculosis, Viral carcinogenesis D09347 Fostamatinib 4件: 46, 49, 61, 66
119 TGFB1 1件: Tuberculosis D09620 Fresolimumab 4件: 51, 85, 222, 274
120 TGFB2 1件: Tuberculosis D09620 Fresolimumab 4件: 51, 85, 222, 274
121 TGFB3 1件: Tuberculosis D09620 Fresolimumab 4件: 51, 85, 222, 274
122 TNF 5件: Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Tuberculosis D00742 Etanercept 17件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285, 298
123 TNF 5件: Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Tuberculosis D00754 Thalidomide 20件: 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331
124 TNF 5件: Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Tuberculosis D01583 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
125 TNF 5件: Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Tuberculosis D02597 Adalimumab 18件: 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 151, 160, 164, 222, 226, 269, 270, 271
126 TNF 5件: Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Tuberculosis D02598 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271
127 TNF 5件: Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Tuberculosis D03441 Certolizumab pegol 8件: 37, 46, 49, 96, 97, 107, 226, 271
128 TNF 5件: Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Tuberculosis D04358 Golimumab 8件: 46, 56, 84, 96, 97, 107, 270, 271
129 TNF 5件: Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Tuberculosis D04687 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331
130 TNF 5件: Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Tuberculosis D05393 Pegsunercept 1件: 46
131 TNF 5件: Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Tuberculosis D08976 Pomalidomide 6件: 28, 34, 51, 85, 227, 331
132 TNF 5件: Viral protein interaction with cytokine and cytokine receptor, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Tuberculosis D09944 Ozoralizumab 1件: 46
133 C3 2件: Tuberculosis, Viral carcinogenesis D11613 Pegcetacoplan 3件: 2, 62, 222
134 VDR 1件: Tuberculosis D00122 Calcifediol 2件: 113, 299
135 VDR 1件: Tuberculosis D00129 Calcitriol 9件: 18, 37, 46, 49, 66, 96, 158, 235, 326
136 VDR 1件: Tuberculosis D00187 Ergocalciferol 6件: 46, 49, 84, 96, 97, 299
137 VDR 1件: Tuberculosis D00188 Cholecalciferol 25件: 6, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 75, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299
138 VDR 1件: Tuberculosis D00299 Dihydrotachysterol 2件: 6, 85
139 VDR 1件: Tuberculosis D00930 Paricalcitol 4件: 19, 66, 218, 238
140 VDR 1件: Tuberculosis D01125 Calcipotriol 2件: 36, 51
141 VDR 1件: Tuberculosis D01518 Alfacalcidol 8件: 41, 46, 49, 50, 96, 107, 235, 238
142 VDR 1件: Tuberculosis D07578 Eldecalcitol 1件: 46
143 CASP9 3件: VEGF signaling pathway, Tuberculosis, Viral myocarditis D11195 Rimiducid 6件: 19, 60, 65, 284, 285, 326
144 CD74 1件: Tuberculosis D08944 Milatuzumab 1件: 49